Regenerative Medical Technology (RMTG) EPS (Basic) Growth (1y) (2019 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn | 39.88% |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn | -102.31% |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 515.34% |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn | -21.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.13% |
| Mar 31, 2026 | -145.93% |
| Dec 31, 2025 | -259.12% |
| Sep 30, 2025 | -344.36% |
| Jun 30, 2025 | 37.34% |
| Mar 31, 2025 | 61.31% |
| Dec 31, 2024 | 64.10% |
| Sep 30, 2024 | 49.26% |
| Jun 30, 2024 | -379.90% |
| Mar 31, 2024 | -2,529.91% |
| Dec 31, 2023 | 27.32% |
| Sep 30, 2023 | -26.80% |
| Jun 30, 2023 | 71.74% |
| Mar 31, 2023 | 95.72% |
| Dec 31, 2022 | -43.76% |
| Sep 30, 2022 | 86.67% |
| Jun 30, 2022 | -92.70% |
| Mar 31, 2022 | -220.74% |
| Dec 31, 2021 | 55.46% |
| Sep 30, 2021 | -1,269.15% |